APA (7th ed.) Citation

A, B., AT, Y., & TG, S. (2026). Outcomes of 16-week extension of anti-VEGF therapy in neovascular age-related macular degeneration. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 61(2), 437. https://doi.org/10.1016/j.jcjo.2025.10.002

Chicago Style (17th ed.) Citation

A, Basilious, Yuan AT, and Sheidow TG. "Outcomes of 16-week Extension of Anti-VEGF Therapy in Neovascular Age-related Macular Degeneration." Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie 61, no. 2 (2026): 437. https://doi.org/10.1016/j.jcjo.2025.10.002.

MLA (9th ed.) Citation

A, Basilious, et al. "Outcomes of 16-week Extension of Anti-VEGF Therapy in Neovascular Age-related Macular Degeneration." Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie, vol. 61, no. 2, 2026, p. 437, https://doi.org/10.1016/j.jcjo.2025.10.002.